Spravato
For individuals struggling with depression symptoms that have not improved enough with traditional treatment, Spravato may offer an alternative option. We understand that those searching for a certified Spravato treatment center are looking for clear information about eligibility, insurance coverage, and what the treatment process actually involves. At Time For Ketamine, Spravato treatment is provided in a medically supervised setting through REMS-certified clinics in both Atlanta and Chattanooga, with a focus on safety, accessibility, and individualized care.
Spravato
For individuals struggling with depression symptoms that have not improved enough with traditional treatment, Spravato may offer an alternative option. We understand that those searching for a certified Spravato treatment center are looking for clear information about eligibility, insurance coverage, and what the treatment process actually involves. At Time For Ketamine, Spravato treatment is provided in a medically supervised setting through REMS-certified clinics in both Atlanta and Chattanooga, with a focus on safety, accessibility, and individualized care.
Conditions We Treat
Table of Contents
Emily Logan APRN, PMHNP-BC
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s.
What Is Spravato?
Spravato is the brand name for esketamine, an FDA-approved nasal spray used for treatment-resistant depression and major depressive disorder with suicidal ideation or behavior. Unlike traditional antidepressants that may take several weeks to produce noticeable changes, Spravato works through a different neurological pathway associated with rapid antidepressant effects.
Spravato for depression is derived from ketamine but is not identical to IV ketamine therapy. Esketamine is a specific molecular component of ketamine delivered as a nasal spray under medical supervision in a certified healthcare setting.
One of the most important distinctions between Spravato and IV ketamine is regulatory approval and insurance coverage. IV ketamine is commonly used off-label for depression and is generally not covered by insurance plans. Spravato, however, received FDA approval for treatment-resistant depression and certain cases of major depressive disorder with suicidal ideation, which means insurance coverage may be available for qualifying patients.
How Does Spravato Work?
Esketamine treatment works differently from standard antidepressants that primarily target serotonin or related neurotransmitters. Spravato acts on the brain’s NMDA receptors within the glutamate system, which plays an important role in neural communication, learning, and mood regulation.
Researchers believe this mechanism may help promote synaptic plasticity and support the formation of new neural connections associated with emotional regulation and cognitive flexibility. Because of this rapid neurological activity, some patients report improvements in depressive symptoms much faster than they experienced with conventional antidepressant medications.
Although individual responses vary, Spravato has become an important option for adults whose depression has not responded adequately to multiple antidepressant trials.
The Spravato Treatment Process
Because Spravato is regulated through the FDA’s REMS program, treatment must occur in a certified healthcare setting under medical supervision. Time For Ketamine is REMS-certified at both our Atlanta and Chattanooga locations.
Treatment sessions involve self-administering the nasal spray in the clinic while medical staff supervise the process and monitor patient safety throughout the appointment. Patients do not take Spravato home or administer it independently outside the clinic setting.
Most treatment protocols begin with sessions twice weekly during the first month. Depending on symptom improvement and provider recommendations, treatment frequency may later transition to weekly sessions and eventually every two weeks for maintenance care.
Although the medication is administered relatively quickly, patients remain in the clinic for observation afterward. Appointments typically last about two hours total, including administration and the post-treatment monitoring period required through the REMS program.
Due to the fact that Spravato can temporarily affect alertness, coordination, and perception, patients must arrange transportation home after every appointment.
Who Qualifies for Spravato?
Spravato is generally prescribed for adults diagnosed with treatment-resistant depression or major depressive disorder with suicidal ideation or behavior.
Treatment-resistant depression typically refers to depressive symptoms that have not adequately improved after at least two antidepressant medications were taken at appropriate doses for a sufficient duration.
Candidates for esketamine treatment may include individuals who:
- Continue experiencing significant depressive symptoms despite medication treatment
- Have tried multiple antidepressants without meaningful improvement
- Experience severe depression affecting work, relationships, or daily functioning
- Have major depressive disorder accompanied by suicidal ideation
- Need an alternative treatment approach after unsuccessful traditional interventions
Before treatment begins, patients complete a medical and psychiatric evaluation to determine clinical appropriateness and review safety considerations.
Insurance pre-authorization is often required before starting treatment. Our team assists patients throughout this process by coordinating documentation, verifying benefits, and helping navigate coverage requirements whenever possible.
What is Lorem Ipsum?
Does Insurance Cover Spravato?
Insurance coverage is one of the primary reasons many patients pursue Spravato instead of IV ketamine infusions. Because Spravato received FDA approval for treatment-resistant depression and major depressive disorder with suicidal ideation, many commercial insurance plans and Medicare may provide coverage for qualifying patients. Coverage varies depending on the individual plan, diagnosis, and medical documentation requirements. In contrast, IV ketamine is generally considered an off-label treatment for depression and is not typically covered by insurance carriers.
The FDA also requires Spravato treatment centers to participate in the REMS program, which helps ensure standardized monitoring and safety protocols. Furthermore, patients may qualify for financial assistance through Janssen CarePath. This is the manufacturer’s patient support program designed to help eligible individuals manage treatment-related costs.
How Effective Is Spravato?
Spravato became FDA-approved following clinical trials demonstrating meaningful symptom improvement in adults with treatment-resistant depression and depression with suicidal ideation when combined with an oral antidepressant.
One advantage of Spravato is its potential accessibility through insurance coverage, which may make long-term treatment more financially realistic for some patients compared to IV ketamine.
The treatment experience itself also differs from IV ketamine therapy. Spravato is administered intranasally through supervised self-administration, while IV ketamine involves intravenous infusion with adjustable dosing protocols. Some patients and providers may prefer one approach over the other depending on symptom severity, treatment history, clinical goals, and financial considerations. However, for certain individuals, IV ketamine may still be recommended when more individualized dosing flexibility or broader off-label treatment applications are clinically appropriate.
Frequently Asked Questions
Is Spravato the Same as Ketamine?
Spravato (esketamine) is derived from ketamine and works through a similar mechanism, but it is not identical. Esketamine is a specific molecular component of ketamine delivered as a nasal spray rather than an IV infusion. Spravato is FDA-approved for treatment-resistant depression and MDD with suicidal ideation, giving it a different regulatory and insurance status than IV ketamine.
Why Would I Choose Spravato Over IV Ketamine Infusions?
The main advantages are FDA approval and insurance coverage potential. Because Spravato is FDA-approved, many insurers may cover it for qualifying patients, significantly reducing out-of-pocket costs. IV ketamine is used off-label for depression and is generally not covered by insurance. Your provider can help determine which option is the better clinical and financial fit.
How Long Does a Spravato Session Take?
Plan for approximately two hours per session. You will self-administer the nasal spray under medical supervision, then remain in the clinic during a monitoring period before being cleared to leave. You will need a driver—you cannot drive yourself home after treatment.
Does Insurance Cover Spravato?
It depends on your plan and whether you meet the clinical criteria. Because Spravato is FDA-approved, many commercial insurers and Medicare cover it for qualifying patients with treatment-resistant depression. Prior authorization is typically required. Our team can assist with the pre-authorization process and connect you with Janssen CarePath patient assistance if needed.
What Is the REMS Program and Why Does It Matter?
REMS stands for Risk Evaluation and Mitigation Strategy. The FDA requires Spravato to be administered only in certified healthcare settings—patients cannot take it at home. This ensures proper monitoring and safety. Time For Ketamine is a REMS-certified Spravato treatment center at both our Atlanta and Chattanooga locations.
Our Providers
At Time For Ketamine, Spravato treatment is delivered by licensed medical professionals experienced in the administration and monitoring of esketamine therapy. Our providers work closely with patients, referring psychiatrists, and treatment teams to help ensure secure, coordinated, and personalized care throughout the treatment process.
Find Spravato Treatment
If you have been researching Spravato clinic near me options or exploring esketamine treatment after multiple unsuccessful antidepressant trials, Time For Ketamine can help you understand whether you may qualify for care. Our REMS-certified Atlanta and Chattanooga clinics provide medically supervised Spravato treatment with guidance through eligibility, insurance coverage, and ongoing treatment planning.
Contact us today to ask about Spravato eligibility and coverage options!